BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 37480137)

  • 1. Novel target and treatment agents for natural killer/T-cell lymphoma.
    Tian XP; Cao Y; Cai J; Zhang YC; Zou QH; Wang JN; Fang Y; Wang JH; Guo SB; Cai QQ
    J Hematol Oncol; 2023 Jul; 16(1):78. PubMed ID: 37480137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updating targets for natural killer/T-cell lymphoma immunotherapy.
    Xue W; Zhang M
    Cancer Biol Med; 2021 Feb; 18(1):52-62. PubMed ID: 33628584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population.
    Chou CC; Tsao CF; Liao CK; You HL; Wang MC; Huang WT
    Exp Mol Pathol; 2021 Feb; 118():104577. PubMed ID: 33242451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.
    Lin N; Ku W; Song Y; Zhu J; Lu Z
    Oncologist; 2019 Sep; 24(9):e905-e913. PubMed ID: 30940744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances and challenges of immunotherapies in NK/T cell lymphomas.
    He L; Chen N; Dai L; Peng X
    iScience; 2023 Nov; 26(11):108192. PubMed ID: 38026157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell dysfunction in natural killer/T-cell lymphoma.
    Feng X; Meng M; Li H; Gao Y; Song W; Di R; Li Z; Zhang X; Zhang M
    Oncoimmunology; 2023; 12(1):2212532. PubMed ID: 37250921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma.
    Xiong J; Cui BW; Wang N; Dai YT; Zhang H; Wang CF; Zhong HJ; Cheng S; Ou-Yang BS; Hu Y; Zhang X; Xu B; Qian WB; Tao R; Yan F; Hu JD; Hou M; Ma XJ; Wang X; Liu YH; Zhu ZM; Huang XB; Liu L; Wu CY; Huang L; Shen YF; Huang RB; Xu JY; Wang C; Wu DP; Yu L; Li JF; Xu PP; Wang L; Huang JY; Chen SJ; Zhao WL
    Cancer Cell; 2020 Mar; 37(3):403-419.e6. PubMed ID: 32183952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances of treatment for nature killer/T-cell lymphoma].
    Wang H; Pan XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1453-8. PubMed ID: 25338606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review on natural killer/T-cell lymphoma.
    He X; Gao Y; Li Z; Huang H
    Hematol Oncol; 2023 Apr; 41(2):221-229. PubMed ID: 34731509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management.
    Tse E; Fox CP; Glover A; Yoon SE; Kim WS; Kwong YL
    Semin Hematol; 2022 Oct; 59(4):198-209. PubMed ID: 36805888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma.
    Peng RJ; Han BW; Cai QQ; Zuo XY; Xia T; Chen JR; Feng LN; Lim JQ; Chen SW; Zeng MS; Guo YM; Li B; Xia XJ; Xia Y; Laurensia Y; Chia BKH; Huang HQ; Young KH; Lim ST; Ong CK; Zeng YX; Bei JX
    Leukemia; 2019 Jun; 33(6):1451-1462. PubMed ID: 30546078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab.
    Qing M; Zhou T; Perova T; Abraham Y; Sweeney C; Krevvata M; Zhang X; Qi M; Gao G; Kim TM; Yao M; Cho SG; Eom HS; Lim ST; Yeh SP; Kwong YL; Yoon DH; Kim JS; Kim WS; Zhou L; Attar R; Verona RI
    Ann Hematol; 2024 Jun; 103(6):1989-2001. PubMed ID: 38233570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase.
    Yang J; Li P; Piao Y; Liu X; Wei L; Sang W; Zhang L; Wang L
    Front Immunol; 2022; 13():829366. PubMed ID: 35371002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment with anti-programmed-death-1 antibody in a relapsed natural killer/T-cell lymphoma patient with multi-line resistance: a case report.
    Lai J; Xu P; Jiang X; Zhou S; Liu A
    BMC Cancer; 2017 Jul; 17(1):507. PubMed ID: 28754096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term eradication of extranodal natural killer/T-cell lymphoma, nasal type, by induced pluripotent stem cell-derived Epstein-Barr virus-specific rejuvenated T cells
    Ando M; Ando J; Yamazaki S; Ishii M; Sakiyama Y; Harada S; Honda T; Yamaguchi T; Nojima M; Ohshima K; Nakauchi H; Komatsu N
    Haematologica; 2020 Mar; 105(3):796-807. PubMed ID: 31296577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential.
    Xiong J; Wang N; Zhong HJ; Cui BW; Cheng S; Sun R; Chen JY; Xu PP; Cai G; Wang L; Sun XJ; Huang JY; Zhao WL
    EBioMedicine; 2021 Oct; 72():103614. PubMed ID: 34628354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full-spectral genome analysis of natural killer/T cell lymphoma highlights impacts of genome instability in driving its progression.
    Chen Z; Huang H; Hong H; Huang H; Weng H; Yu L; Xiao J; Wang Z; Fang X; Yao Y; Yue JX; Lin T
    Genome Med; 2024 Apr; 16(1):48. PubMed ID: 38566223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
    Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
    J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma.
    Liu Z; Sarathkumara YD; Chan JKC; Kwong YL; Lam TH; Ip DKM; Chiu BC; Xu J; Su YC; Proietti C; Cooper MM; Yu KJ; Bassig B; Liang R; Hu W; Ji BT; Coghill AE; Pfeiffer RM; Hildesheim A; Rothman N; Doolan DL; Lan Q
    Sci Rep; 2021 Dec; 11(1):23664. PubMed ID: 34880297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
    Adabifirouzjaei F; Khazai B; Azami G; Shoja-E-Razavi G
    J Med Case Rep; 2021 Oct; 15(1):539. PubMed ID: 34702349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.